Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Dixon LB, Dickerson F, Bellack AS, Bennett M, Dickinson D, Goldberg RW, Lehman A, Tenhula WN, Calmes C, Pasillas RM, Peer J, Kreyenbuhl J; Schizophrenia Patient Outcomes Research Team (PORT).

Schizophr Bull. 2010 Jan;36(1):48-70. doi: 10.1093/schbul/sbp115. Epub 2009 Dec 2. Review.

PMID:
19955389
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009.

Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB; Schizophrenia Patient Outcomes Research Team (PORT).

Schizophr Bull. 2010 Jan;36(1):94-103. doi: 10.1093/schbul/sbp130. Epub 2009 Dec 2.

PMID:
19955388
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation.

Satterthwaite TD, Wolf DH, Rosenheck RA, Gur RE, Caroff SN.

J Clin Psychiatry. 2008 Dec;69(12):1869-79. Epub 2008 Dec 2.

PMID:
19192477
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis.

Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM.

Lancet. 2009 Jan 3;373(9657):31-41. doi: 10.1016/S0140-6736(08)61764-X. Epub 2008 Dec 6.

PMID:
19058842
[PubMed - indexed for MEDLINE]
5.

Extrapyramidal side-effects of antipsychotics in a randomised trial.

Miller DD, Caroff SN, Davis SM, Rosenheck RA, McEvoy JP, Saltz BL, Riggio S, Chakos MH, Swartz MS, Keefe RS, Stroup TS, Lieberman JA; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators.

Br J Psychiatry. 2008 Oct;193(4):279-88. doi: 10.1192/bjp.bp.108.050088.

PMID:
18827289
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Should we treat auditory hallucinations with repetitive transcranial magnetic stimulation? A metaanalysis.

Tranulis C, Sepehry AA, Galinowski A, Stip E.

Can J Psychiatry. 2008 Sep;53(9):577-86.

PMID:
18801220
[PubMed - indexed for MEDLINE]
7.

Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study.

Sikich L, Frazier JA, McClellan J, Findling RL, Vitiello B, Ritz L, Ambler D, Puglia M, Maloney AE, Michael E, De Jong S, Slifka K, Noyes N, Hlastala S, Pierson L, McNamara NK, Delporto-Bedoya D, Anderson R, Hamer RM, Lieberman JA.

Am J Psychiatry. 2008 Nov;165(11):1420-31. doi: 10.1176/appi.ajp.2008.08050756. Epub 2008 Sep 15. Erratum in: Am J Psychiatry. 2008 Nov;165(11):1495.

PMID:
18794207
[PubMed - indexed for MEDLINE]
8.

Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia.

Swanson JW, Swartz MS, Van Dorn RA, Volavka J, Monahan J, Stroup TS, McEvoy JP, Wagner HR, Elbogen EB, Lieberman JA; CATIE investigators.

Br J Psychiatry. 2008 Jul;193(1):37-43. doi: 10.1192/bjp.bp.107.042630.

PMID:
18700216
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Maintenance treatment with transcranial magnetic stimulation in a patient with late-onset schizophrenia.

Poulet E, Brunelin J, Kallel L, D'Amato T, Saoud M.

Am J Psychiatry. 2008 Apr;165(4):537-8. doi: 10.1176/appi.ajp.2007.07060868. No abstract available.

PMID:
18381921
[PubMed - indexed for MEDLINE]
10.

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.

Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rössler A, Grobbee DE; EUFEST study group.

Lancet. 2008 Mar 29;371(9618):1085-97. doi: 10.1016/S0140-6736(08)60486-9.

PMID:
18374841
[PubMed - indexed for MEDLINE]
11.

Successful use of maintenance rTMS for 8 months in a patient with antipsychotic-refractory auditory hallucinations.

Thirthalli J, Bharadwaj B, Kulkarni S, Gangadhar BN, Kharawala S, Andrade C.

Schizophr Res. 2008 Mar;100(1-3):351-2. doi: 10.1016/j.schres.2008.01.003. Epub 2008 Feb 5. No abstract available.

PMID:
18252271
[PubMed - indexed for MEDLINE]
12.

A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.

Meltzer HY, Bobo WV, Roy A, Jayathilake K, Chen Y, Ertugrul A, Anil Yağcioğlu AE, Small JG.

J Clin Psychiatry. 2008 Feb;69(2):274-85.

PMID:
18232726
[PubMed - indexed for MEDLINE]
13.

Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety.

Citrome L.

J Clin Psychiatry. 2007 Dec;68(12):1876-85.

PMID:
18162018
[PubMed - indexed for MEDLINE]
14.

A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Sacco KA, Weinberger AH, Dudas MM, Allen TM, Creeden CL, Potenza MN, Feingold A, Jatlow PI.

Biol Psychiatry. 2008 Jun 1;63(11):1092-6. Epub 2007 Dec 21.

PMID:
18096137
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.

Gaebel W, Riesbeck M, Wölwer W, Klimke A, Eickhoff M, von Wilmsdorff M, Jockers-Scherübl MC, Kühn KU, Lemke M, Bechdolf A, Bender S, Degner D, Schlösser R, Schmidt LG, Schmitt A, Jäger M, Buchkremer G, Falkai P, Klingberg S, Köpcke W, Maier W, Häfner H, Ohmann C, Salize HJ, Schneider F, Möller HJ; German Study Group on First-Episode Schizophrenia.

J Clin Psychiatry. 2007 Nov;68(11):1763-74.

PMID:
18052570
[PubMed - indexed for MEDLINE]
16.

The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.

Moore TA, Buchanan RW, Buckley PF, Chiles JA, Conley RR, Crismon ML, Essock SM, Finnerty M, Marder SR, Miller DD, McEvoy JP, Robinson DG, Schooler NR, Shon SP, Stroup TS, Miller AL.

J Clin Psychiatry. 2007 Nov;68(11):1751-62.

PMID:
18052569
[PubMed - indexed for MEDLINE]
17.

Effects of repetitive transcranial magnetic stimulation on auditory hallucinations refractory to clozapine.

Rosa MO, Gattaz WF, Rosa MA, Rumi DO, Tavares H, Myczkowski M, Sartorelli MC, Rigonatti SP, Elkis H, Cabral SB, Teixeira MJ, Marcolin MA.

J Clin Psychiatry. 2007 Oct;68(10):1528-32.

PMID:
17960967
[PubMed - indexed for MEDLINE]
18.

Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Haddad PM, Sharma SG.

CNS Drugs. 2007;21(11):911-36. Review.

PMID:
17927296
[PubMed - indexed for MEDLINE]
19.

Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.

Kumra S, Kranzler H, Gerbino-Rosen G, Kester HM, De Thomas C, Kafantaris V, Correll CU, Kane JM.

Biol Psychiatry. 2008 Mar 1;63(5):524-9. Epub 2007 Jul 25.

PMID:
17651705
[PubMed - indexed for MEDLINE]
20.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk